Indian Pharma Urges US to Maintain Tariff Exemption for Generics Amid Trade Talks, ETPharma

New Delhi: Amid a renewed push by the US President Donald Trump to impose tariffs on generic drugs, drugmakers in India are pushing for maintaining the status quo, arguing that remains unfeasible in the proposed two year window and imposing
Read more...